KANGER (0170) - KANGER INTERNATIONAL BHD

Mr.Gekko

Well-known member
Kanger International Bhd, an investment holding company, engages in the research, development, manufacture, and trade of bamboo flooring and related products in the People's Republic of China. It operates through three segments: Investment Holding, Manufacturing and Trading, and Research and Development. It operates the business across North America, Europe, and Asia.


Dengar kata bakal dapat kontrak distribute vacine covid
 

Mr.Gekko

Well-known member
KUALA LUMPUR: Kanger International Bhd (KIB) has inked a collaboration agreement with China-based Sinopharm Group Hunan Changde Medical Co Ltd (Sinopharm Group) for the distribution of Covid-19 vaccines developed by China National Biotech Group Company (CNBG) in Malaysia.

KIB, in a Bursa Malaysia filing today said the distribution of Covid-19 vaccines will only be executed after obtaining approvals from local authorities namely, the Ministry of Health Malaysia, National Pharmaceutical Regulatory Agency and other relevant authorities.

Sinopharm Group is engaged in sale of medical supplies and equipment and a subsidiary of China National Pharmaceutical Group Corporation (CNPG), a large Chinese state-owned healthcare group.

Under the agreement, Sinopharm Group has appointed KIB as the sole distributor for the vaccines, medical devices and products in Malaysia.

KIB will also undertake the marketing and promotion of Sinopharm Group's products in Malaysia, however, both parties will sign a separate agreement in regards to specific product category, price, purchase price and payment method.

This agreement shall take effect for a period of three years effective from 25 September 2020 until 24 September 2023, the Bursa Malaysia filing noted.

To note, Sinopharm CNBG's Covid-19 vaccines are now in final stages of testing and has already entered Phase 3 trials - the final stage before being approved for general use - in more than 10 countries namely United Arab Emirates (UAE), Bahrain, Peru, Morocco, Argentina, Pakistan, Serbia and Jordan.

While the final stage of trials is still underway in many countries, China and UAE have approved the emergency use of Sinopharm CNBG's Covid-19 vaccine for those in high-risk groups such as medical workers.

Notably, KIB's newly appointed chairman Datuk Nur Jazlan Mohamed, former Deputy Minister of Home Affairs from July 2015 to May 2018, is also expected to boost the company's application for approvals for Sinopharm CNBG's Covid-19 vaccine distribution in the country.

Several hundred thousand people have already taken the Covid-19 vaccine without a single case of infection or adverse effects.

With these positive outcomes, the Sinopharm CNBG's Covid-19 vaccine is expected to enter the market as early as December 2020.
 

fazruljalaluddin

Active member

pemegang saham terbesar kanger, jual saham diorg semalam, RM0.175 sebanyak 90 juta unit. tiada update terbaru drp plan diorg untuk buat glove dan distribute vaksin 😳
 

Mr.Gekko

Well-known member

pemegang saham terbesar kanger, jual saham diorg semalam, RM0.175 sebanyak 90 juta unit. tiada update terbaru drp plan diorg untuk buat glove dan distribute vaksin 😳

patut la terus junam.
tak sempat nak jual di 20sen.
saya beli 0.17
 

fazruljalaluddin

Active member
patut la terus junam.
tak sempat nak jual di 20sen.
saya beli 0.17

jangan risau tuan, saya perhatikan dlm 2 minggu ni, xde la menjunam.., tapi naik-turun situ jugak. rm0.17-0.18 sen. simpan je dulu. rilek2 ✌🏻😊

saya bukan trader, tetapi lebih kepada melabur. bila nampak biggest shareholder lepaskan saham, banyak pertanyaan yg tak terjawab. update terkini pun tiada, sebab tu saya concern 🧐

mula2 nak join the hype buat glove, pastu senyap.. tiba2 dah jumpa vaksin, pun annouce nak distribute vaksin, pastu senyap.. saya rasa ada something wrong dlm pengurusan diorg ni.

xpe la, saya pun bukannya expert, harap2 saya salah la ya 🙏🏻
 

Mr.Gekko

Well-known member
jangan risau tuan, saya perhatikan dlm 2 minggu ni, xde la menjunam.., tapi naik-turun situ jugak. rm0.17-0.18 sen. simpan je dulu. rilek2 ✌🏻😊

saya bukan trader, tetapi lebih kepada melabur. bila nampak biggest shareholder lepaskan saham, banyak pertanyaan yg tak terjawab. update terkini pun tiada, sebab tu saya concern 🧐

mula2 nak join the hype buat glove, pastu senyap.. tiba2 dah jumpa vaksin, pun annouce nak distribute vaksin, pastu senyap.. saya rasa ada something wrong dlm pengurusan diorg ni.

xpe la, saya pun bukannya expert, harap2 saya salah la ya 🙏🏻

hehe takpe tuan.
btul dh info tu
saya hairan kalau biggest shareholder pun exit dr comp
takkan yg lain nak relax lagi.
nampak mcm tinggal kena goreng je tu.
tp still ada yg beli tu itu harga die stay je
cuma takpe try counter lain pulak.:p
 

fazruljalaluddin

Active member
hehe takpe tuan.
btul dh info tu
saya hairan kalau biggest shareholder pun exit dr comp
takkan yg lain nak relax lagi.
nampak mcm tinggal kena goreng je tu.
tp still ada yg beli tu itu harga die stay je
cuma takpe try counter lain pulak.:p

diorg tak keluar dari syarikat. cuma jual sebahagian dari share yang diorg pegang. maksudnya wu wai kong (pemegang terbesar saham syarikat kanger sebelum ni) masih lagi bersama kanger.

kadang2 ada reason diorg sendiri, tunggu je la kot2 esok lusa dia keluar berita ke apa 😊
 

Mr.Gekko

Well-known member
Jual awal.
Huhu

Anthony Anderson Reaction GIF
 

fazruljalaluddin

Active member

hmmm.... jangan fikir pelabur bodoh 😎

"As they say, ‘there is many a slip between the cup and the lip’. It is easy for some listed companies to announce intentions and action plans because such announcements are cheap; it does not cost them anything to announce such things.

Whether there will be actualisation of these is another point altogether. Tie-ups and memorandums of understanding are another kettle of fish that may result in nothing.

Sometimes such announcements result in spectacular price increases only for the prices to fall flat later. Some punting-minority shareholders, who like to live dangerously, will invest hoping to ride the upside and get out before the downside kicks in.

Not every minority shareholder can time the company’s share price trajectory so perfectly and mechanically. Many a minority shareholder has lost money because they went in too high and were unable to get out before the often-sudden fall in the share prices.

Some have referred to such dubious announcements as mere noise meant to drive up share prices.

Minority shareholders must form a view on the likelihood of such announcements bearing fruit at the end of the day.

The informed minority shareholder will also consider, among others, the financial strength of the company, its reputation/performance track record and the reputation of the board and major shareholders before parting with their money by investing in such companies.

Minority shareholders must always remember the maxim that ‘if it is too good to be true, it probably is … too good to be true"

Devanesan Evanson
 

Recommended Brokers

Kami hanya memilih broker yang terbaik!

INTRADAY Squawk

Klik Play ▶️ / tajuk berita untuk dengar Recap Pasaran

Live Forex Price

Live Crypto Price

Top